FERRING PHARMACEUTICALS A/S: Financial statements 2017
CVR: 16313440
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
FERRING PHARMACEUTICALS A/S (CVR 16313440) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 1,332,355,000 and a net result of DKK 54,688,000 compared with DKK 50,325,000 the year before. That is an increase of 8.7% compared with the year before. The profit margin was 4.1%. Equity in the 2017 report amounted to DKK 112,105,000. The solvency ratio was 29.7%. The company had 548 employees in the financial year.
- Revenue
- DKK 1,332,355,000
- Gross Profit
- DKK 1,332,355,000
- Profit/Loss
- DKK 54,688,000
- Equity
- DKK 112,105,000
- Total Assets
- DKK 376,926,000
- Employees
- 548
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 1.3 mia. | 1.3 mia. | 54.7 mio. | 112.1 mio. | 548 |
| 2016 | 1.2 mia. | 1.2 mia. | 50.3 mio. | 97.4 mio. | 491 |
| 2015 | 1.3 mia. | 1.3 mia. | 51.6 mio. | 86.1 mio. | 467 |
| 2014 | 1.2 mia. | 1.2 mia. | 47.9 mio. | 109.5 mio. | 463 |
| 2013 | 1.1 mia. | - | 43.8 mio. | 117.6 mio. | 407 |
Official annual report
Keep an eye on FERRING PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
FERRING PHARMACEUTICALS A/S has published its annual report for 2016. Revenue came to DKK 1,225,924,000, and the net result was DKK 50,325,000.
As of March 14, 2017, Per Gunnar Falk has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of March 14, 2017, Pascal Rene Olivier Danglas has left the board of directors of FERRING PHARMACEUTICALS A/S.
About FERRING PHARMACEUTICALS A/S
FERRING PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named FERRING NORDIC PHARMACEUTICALS A/S and A/S PSE 38 NR. 1587. The management consists of Jan Peutzfeldt, Ingbritt Tolstrup Birk and Jesper Thomsen. The board consists of Marianne Kock (chair), Dag Frederik Arfst Paulsen and Jean-Frederic Paulsen. The company is owned by Ferring B.V.. The company has 522 employees (2026). In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. Equity in the 2025 report amounted to DKK 315,220,000.